Shanghai Junshi Biosciences Co., Ltd. (688180.SS)
CNY 30.2
(0.77%)
CNY 30.2
(0.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.48 Billion | 1.45 Billion | 4.02 Billion | 1.59 Billion | 775.08 Million | 934 Thousand |
| Cost of Revenue | 784.22 Million | 526.28 Million | 1.25 Billion | 372.53 Million | 90.68 Million | 267 Thousand |
| Gross Profit | 698.62 Million | 927.21 Million | 2.76 Billion | 1.22 Billion | 684.4 Million | 667 Thousand |
| Operating Expenses | 3.21 Billion | 3.64 Billion | 3.35 Billion | 2.89 Billion | 1.47 Billion | 684.79 Million |
| Selling, General and Administrative Expenses | 1.4 Billion | 1.29 Billion | 1.38 Billion | 1.13 Billion | 564.28 Million | 145.14 Million |
| Research and Development Expenses | 1.93 Billion | 2.38 Billion | 2.06 Billion | 1.77 Billion | 946.1 Million | 538.18 Million |
| Other Expenses | -11 Million | -34.18 Million | -91.89 Million | -18.55 Million | -31.54 Million | 17.02 Million |
| Cost and Expenses | 3.95 Billion | 4.17 Billion | 4.61 Billion | 3.26 Billion | 1.56 Billion | 685.05 Million |
| Operating Income | -2.45 Billion | -2.67 Billion | -685.33 Million | -1.67 Billion | -764.44 Million | -684.12 Million |
| Interest Expense | 29 Million | 29.37 Million | 21.83 Million | 29.39 Million | 13.3 Million | 2.08 Million |
| Income Tax Expense | 43.99 Million | -93.1 Million | 135.53 Million | -3.82 Million | -18.89 Million | -1.21 Million |
| Earnings before Tax | -2.49 Billion | -2.67 Billion | -592.64 Million | -1.66 Billion | -763.12 Million | -717.71 Million |
| Net Income | -2.28 Billion | -2.58 Billion | -728.18 Million | -1.66 Billion | -744.23 Million | -716.41 Million |
| Earnings Per Share Basic | -2.32 | -2.81 | -0.82 | -1.91 | -0.95 | -1.19 |
| Earnings Per Share Diluted | -2.32 | -2.81 | -0.82 | -1.91 | -0.95 | -1.19 |
| Weighted Average Shares Outstanding | 984.23 Million | 918.48 Million | 890.01 Million | 872.49 Million | 784.14 Million | 601.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 984.23 Million | 918.48 Million | 890.01 Million | 872.49 Million | 784.14 Million | 601.91 Million |
| Gross Margin | 0.47 | 0.64 | 0.69 | 0.77 | 0.88 | 0.71 |
| EBIT Margin | -1.46 | -1.64 | -0.11 | -0.96 | -0.91 | -695.16 |
| Profit Margin | -1.54 | -1.78 | -0.18 | -1.04 | -0.96 | -767.04 |
| EBITDA | -2.15 Billion | -2.28 Billion | -259.22 Million | -1.48 Billion | -687.25 Million | -686.14 Million |
| Earnings Before Tax Margin | -1.66 | -1.84 | -0.17 | -1.05 | -0.99 | -732.47 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 479.62 Million | 405.25 Million | 375.16 Million | 509.82 Million | 1.48 Billion | -669.7 Million |
| Cost of Revenue | 114.91 Million | 102.7 Million | 108.09 Million | 265.29 Million | 784.22 Million | 84.68 Million |
| Gross Profit | 364.7 Million | 302.54 Million | 267.06 Million | 244.53 Million | 698.62 Million | -754.39 Million |
| Operating Expenses | 699.99 Million | 625.22 Million | 582.18 Million | 1.18 Billion | 3.21 Billion | -17.33 Million |
| Selling, General and Administrative Expenses | 383.65 Million | 488.56 Million | 312.2 Million | 458.42 Million | - | 298.71 Million |
| Research and Development Expenses | 327.89 Million | 270.08 Million | 276.29 Million | 636.61 Million | - | 322.02 Million |
| Other Expenses | 11.55 Million | -5.39 Million | 6.31 Million | -91.06 Million | -108.44 Million | -11.43 Million |
| Cost and Expenses | 814.91 Million | 727.93 Million | 690.27 Million | 1.45 Billion | 3.99 Billion | -305.85 Million |
| Operating Income | -335.28 Million | -322.38 Million | -315.11 Million | -941.57 Million | -2.51 Billion | -291.31 Million |
| Interest Expense | 12.22 Million | 12.7 Million | 11.68 Million | - | 29 Million | 7.25 Million |
| Income Tax Expense | 530.47 Thousand | 452.4 Thousand | 3.09 Million | 96.38 Million | 43.99 Million | -1.89 Million |
| Earnings before Tax | -304.26 Million | -388.34 Million | -289.21 Million | -872.79 Million | -2.43 Billion | -431.68 Million |
| Net Income | -281.81 Million | -362.66 Million | -283.02 Million | -876.61 Million | -2.28 Billion | -410.39 Million |
| Earnings Per Share Basic | -0.29 | -0.37 | -0.29 | -0.89 | - | -0.42 |
| Earnings Per Share Diluted | -0.29 | -0.37 | -0.29 | -0.89 | - | -0.42 |
| Weighted Average Shares Outstanding | 984.87 Million | 985.01 Million | 985.01 Million | 985.01 Million | 984.23 Million | 985.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 984.87 Million | 985.01 Million | 985.01 Million | 985.01 Million | 984.23 Million | 985.68 Million |
| Gross Margin | 0.76 | 0.75 | 0.71 | 0.48 | 0.47 | 1.13 |
| EBIT Margin | -0.61 | -0.80 | -0.84 | -1.68 | - | 0.43 |
| Profit Margin | -0.59 | -0.89 | -0.75 | -1.72 | -1.54 | 0.61 |
| EBITDA | -292.04 Million | -322.38 Million | -316.44 Million | -854.25 Million | - | -291.31 Million |
| Earnings Before Tax Margin | -0.70 | -0.80 | -0.84 | -1.85 | -1.70 | 0.43 |
IPSEF
8455
LOM
0535
SIMPLEXINF
6592